Target CEO Michael Fiddelke wants to cut prices on apparel, home goods and daily essentials by 5% to 20% as part of a new strategy.

Viking Therapeutics' leading candidate posted strong mid-stage data and is undergoing phase 3 studies. Though there are some risks, the stock could soar if it can pass the upcoming clinical and ...